Bringing Ocular Imaging to Primary Care Practices

EP: 1.Overview of Geographic Atrophy (GA)

EP: 2.Patient Communication Regarding Visual Function in Geographic Atrophy

EP: 3.Disease Burden and Tools to Manage Geographic Atrophy

EP: 4.Impact of Geographic Atrophy on the Caregiver

EP: 5.Discussing Management of Age-Related Macular Degeneration (AMD) with the Patient

EP: 6.Progression of Geographic Atrophy Over Time

EP: 7.Imaging Modalities in Geographic Atrophy

EP: 8.Geographic Atrophy Management in Clinical Practice

EP: 9.Pathophysiology, Treatment Targets and Options in Geographic Atrophy

EP: 10.Pegcetacoplan for Treatment of Geographic Atrophy

EP: 11.Frequency of Pegcetacoplan Administration for Geographic Atrophy Treatment

EP: 12.Treatment of Both Eyes and Subfoveal Lesions in Geographic Atrophy

EP: 13.Pegcetacoplan and Monitoring in Geographic Atrophy

EP: 14.Other Complement Inhibitors for Geographic Atrophy Treatment

EP: 15.Guidance for Treatment Selection in Geographic Atrophy

EP: 16.Ensuring Adherence to Geographic Atrophy Treatment

EP: 17.Introduction of New Geographic Atrophy Treatments in Practice

EP: 18.Improving Referral for Geographic Atrophy

Now Viewing

EP: 19.Bringing Ocular Imaging to Primary Care Practices

EP: 20.Advice to Physicians Treating Geographic Atrophy

Nancy M. Holekamp, MD, FASRS: Nora, you’re a world-class ocular imager. This is where I think AI could help that dynamic. Do you see a future where we will have software on our OCT [optical coherence tomography] machines that will make the diagnosis of GA [geographic atrophy], for not only us but also the primary eye care provider, so that it’s not a question of whether they’re right or wrong. I see AI as a very valuable tool on correct diagnosis prompting a correct and timely referral.

Eleonora Lad, MD, PhD: Yes, in fact, they are. Thank you for asking this question. I’m excited because there are tools in development for this, especially for diagnosing geographic atrophy and predicting which patients will develop geographic atrophy. Some AI tools predict speed of progression for our patients. Hopefully it will be an easy readout, such as others that we’re used to: visual field readout, ECGs [electrocardiograms], and other areas of medicine that could be very useful to our referring colleagues.

Transcript edited for clarity